Clinical trial Recruiting at 1 site Interventional Ages 22 and up

Using Vagus Nerve Stimulation and Robotic Mobilization for Patients with Prolonged Disorders of Consciousness

Official title: Use of Paired Vagus Nerve Stimulation in Mobilization of Patients With Prolonged Disorders of Consciousness: A Pilot Feasibility Study

Run by Icahn School of Medicine at Mount Sinai · NCT06930716 · Data updated 2026-11-12

This study is testing if combining a special nerve stimulation treatment with robotic help to move can improve the recovery of patients who have been in a prolonged state of unconsciousness.

Quick facts

Study typeInterventional
Ages22 Years and up
SexAll
Enrollment15 (estimated)
SponsorIcahn School of Medicine at Mount Sinai
Academic / other
Locations1 site (New York, New York)
StatusRecruiting
StartedAugust 12, 2025
Main results expectedDecember 30, 2027
Study endsDecember 30, 2027
Registry record updatedJune 18, 2026
Trial IDNCT06930716 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are patients diagnosed with prolonged disorders of consciousness lasting more than 3 months post-injury.

Probably not a fit

Patients who have emerged from a minimally conscious state or those deemed medically unsafe for physical therapy will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the combined effects of transauricular vagus nerve stimulation (taVNS) and robotic tilt table mobilization (RTTM) on patients with prolonged disorders of consciousness (pDOC). Participants will undergo a baseline assessment followed by a standard care phase, a mobilization-only phase, and then a phase combining both interventions. The study aims to evaluate safety and efficacy through various assessments over a 12-month period. Data on healthcare utilization will also be collected to understand the broader impact of the interventions.

Why it matters

Potential benefit: If successful, this approach could enhance recovery and functional outcomes for patients with prolonged disorders of consciousness.

How similar studies have gone: While individual modalities have shown promise, this specific combination of taVNS and RTTM has not been previously tested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients with a diagnosis of pDOC (includes coma, VS/UWS, MCS, MCS +, MCS-) as defined as disorder of consciousness (DOC) greater than 6 weeks post onset
* Patients deemed medically safe to participate in physical therapy (PT) as evaluated by the study physicians.

Exclusion Criteria:

* Patients who have emerged from MCS (CRS-R score 6 on Motor Function scale and/or 2 on Communication Scale).
* Patients medically unsafe for participation in PT as indicated by one of the study physicians (including but not limited to those receiving intravenous sedation, those with integumentary breakdown or known pressure injuries, those with cardiovascular or cerebrovascular conditions precluding initiation of physical therapy \[ie uncontrolled intracranial pressure, severe symptomatic orthostatic hypotension, etc.).
* Patients with DOC less than 6 weeks post onset will also be excluded.
* Patients who do not meet technical requirements of the RTTM device will be excluded

  * weighing greater than 135 kg
  * length of legs below 75 cm or above 100 cm,
  * fixed contractures of lower extremity including hip, knee, ankle, or foot).
* Does not have an identified care partner or legally authorized representative to consent to participation

Where it's running

  • Abilities Research Center, Icahn School of Medicine at Mount Sinai
    New York, New York, United States
    Recruiting

Study contacts

  • Principal investigator: Jenna Tosto-Mancuso — Icahn School of Medicine at Mount Sinai
  • Study coordinator: Jenna Tosto-Mancuso, PT, DPT, NCS
  • Email: ARCClinic@mountsinai.org
  • Phone: 212-241-8454

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.